LYMPHOPROLIFERATIVE DISORDER
Clinical trials for LYMPHOPROLIFERATIVE DISORDER explained in plain language.
Never miss a new study
Get alerted when new LYMPHOPROLIFERATIVE DISORDER trials appear
Sign up with your email to follow new studies for LYMPHOPROLIFERATIVE DISORDER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo shows promise for untreated lymphoma patients
Disease control Recruiting nowThis study tests a combination of two drugs, acalabrutinib and obinutuzumab, in people with untreated, slow-growing types of non-Hodgkin lymphoma, including follicular lymphoma. The goal is to see if this drug pair can shrink or eliminate cancer. About 49 adults will take part. T…
Matched conditions: LYMPHOPROLIFERATIVE DISORDER
Phase: PHASE2 • Sponsor: Emory University • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
New hope: immune drug targets Virus-Linked cancers
Disease control Recruiting nowThis study tests whether the drug nivolumab can slow or stop the growth of certain cancers linked to the Epstein-Barr virus. About 40 people aged 12 and older whose cancers did not respond to standard treatments will receive nivolumab every two weeks. The goal is to see if the dr…
Matched conditions: LYMPHOPROLIFERATIVE DISORDER
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 14, 2026 12:02 UTC
-
Massive cancer registry aims to unlock better treatments for kids
Knowledge-focused Recruiting nowThis study is a large registry for children and young adults with cancer. It collects health information and leftover tumor or blood samples over time. The goal is to help doctors find better ways to treat and care for these patients. Up to 75,000 people will take part.
Matched conditions: LYMPHOPROLIFERATIVE DISORDER
Sponsor: Children's Oncology Group • Aim: Knowledge-focused
Last updated May 17, 2026 04:17 UTC
-
Blood cancer Patients' samples fuel future research
Knowledge-focused Recruiting nowThis study collects blood, bone marrow, and tissue samples from up to 15,000 people with blood cancers or related disorders. The samples are stored and used for future research to better understand these diseases. Participants do not receive any treatment as part of this study. T…
Matched conditions: LYMPHOPROLIFERATIVE DISORDER
Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Knowledge-focused
Last updated May 14, 2026 12:02 UTC
-
Gene clues may explain lingering low blood counts after CAR-T
Knowledge-focused Recruiting nowThis study looks at how gene changes (called germline and somatic variants) affect low blood cell counts after CAR-T therapy in people with multiple myeloma or certain lymphomas. About one-third of patients have low blood counts that last more than 30 days after treatment. Resear…
Matched conditions: LYMPHOPROLIFERATIVE DISORDER
Phase: NA • Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated May 11, 2026 20:38 UTC